BMRN vs MAC · P/E 40, rev $2.85B vs rev $918.2M
Biomarin Pharmaceutical Inc (BMRN) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MAC currently screens at market cap $4.41B.
Not investment advice. Open the BMRN and MAC stock pages for the full models.
Not investment advice.